The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Stadler, Walter M.
keywords Clinical Trials as Topic
One or more keywords matched the following items that are connected to Stadler, Walter M.
Item TypeName
Academic Article Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer.
Academic Article Development of target-based antineoplastic agents.
Academic Article New trial designs to assess antitumor and antiproliferative agents in prostate cancer.
Academic Article Angiogenesis inhibitors.
Academic Article Angiogenesis inhibitors in genitourinary cancers.
Academic Article Clinical trial designs for cytostatic agents.
Academic Article Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
Academic Article Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
Academic Article Sorafenib.
Academic Article New targets, therapies, and toxicities: lessons to be learned.
Academic Article Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Academic Article Recommended changes to oncology clinical trial design: revolution or evolution?
Academic Article The cure of bladder cancer: the need for multidisciplinary efforts.
Academic Article Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Academic Article Pazopanib in renal cell carcinoma.
Academic Article Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Academic Article Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer.
Academic Article Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Academic Article Optimizing the doses of cancer drugs after usual dose finding.
Search Criteria
  • Clinical Trials as Topic